Inhaled Steroid Treatment as Regular Therapy in Early Asthma
Inhaled Steroid Treatment as Regular Therapy in Early Asthma
A study of the effect of the early treatment with Pulmicort of newly diagnosed asthma.
 Patients will receive either Pulmicort or a non-active treatment for three years. Neither
 patients or investigators will be aware of the treatment received. After three years of
 treatment all patients will receive Pulmicort for 2 further years.
Inclusion Criteria:

 -  Male or female patients aged between 6 and 60 years

 -  diagnosed with asthma within 2 years of starting the study

 -  Ability to use a Turbuhaler

 Exclusion Criteria:

 -  Symptoms indicating asthma (e.g. wheezing) for more than two years prior to starting
 the study

 -  A history of the use of treatments like Pulmicort for more than 30 days per year in
 the two years before starting the study

 -  Regular daily treatment for asthma for more than two years before starting the study